Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer [ID5110]
In development
Reference number: GID-TA11023
Expected publication date: TBC
Following discussion with the company and NHS England, there will be an additional committee meeting to discuss a managed access proposal. The meeting will be on 12th November 2025, and will be held in private.